Sleep disorders in chronic obstructive pulmonary disease: Etiology, impact, and management

Rohit Budhiraja, Tauseef A. Siddiqi, Stuart F. Quan

    Research output: Contribution to journalReview articlepeer-review

    122 Scopus citations


    Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality and may frequently be complicated by sleep disorders. Insomnia and obstructive sleep apnea are commonly encountered in patients with COPD. Nocturnal hypoxemia is also prevalent in COPD may occur despite adequate awake oxygenation and can be especially severe in rapid eye movement sleep. Additionally, several factors-some of them unique to COPD-can contribute to sleep-related hypoventilation. Recognition of hypoventilation can be vital as supplemental oxygen therapy itself can acutely worsen hypoventilation and lead to disastrous consequences. Finally, accruing data establish an association between restless leg syndrome and COPD-an association that may be driven by hypoxemia and/or hypercapnia. Comorbid sleep disorders portend worse sleep quality, diminished quality of life, and multifarious other adverse consequences. The awareness and knowledge regarding sleep comorbidities in COPD has continued to evolve over past many years. There are still several lacunae, however, in our understanding of the etiologies, impact, and therapies of sleep disorders, specifi cally in patients with COPD. This review summarizes the latest concepts in prevalence, pathogenesis, diagnosis, and management of diverse sleep disorders in COPD.

    Original languageEnglish (US)
    Pages (from-to)259-270
    Number of pages12
    JournalJournal of Clinical Sleep Medicine
    Issue number3
    StatePublished - 2015


    • COPD
    • Hypoventilation
    • Insomnia
    • Obstructive sleep apnea
    • Restless legs syndrome

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine
    • Neurology
    • Clinical Neurology


    Dive into the research topics of 'Sleep disorders in chronic obstructive pulmonary disease: Etiology, impact, and management'. Together they form a unique fingerprint.

    Cite this